WallStreetZenWallStreetZen

NASDAQ: TARS
Tarsus Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for TARS

Based on 5 analysts offering 12 month price targets for Tarsus Pharmaceuticals Inc.
Min Forecast
$30.00-6.86%
Avg Forecast
$48.00+49.02%
Max Forecast
$59.00+83.17%

Should I buy or sell TARS stock?

Based on 5 analysts offering ratings for Tarsus Pharmaceuticals Inc.
Buy
Strong Buy
2 analysts 40%
Buy
2 analysts 40%
Hold
1 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TARS stock forecasts and price targets.

TARS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-06
lockedlocked$00.00+00.00%2024-02-29
lockedlocked$00.00+00.00%2024-02-28
lockedlocked$00.00+00.00%2024-02-28
lockedlocked$00.00+00.00%2024-02-28

1 of 1

Forecast return on equity

Is TARS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is TARS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

TARS revenue forecast

What is TARS's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$102.0M+484.78%
Avg 2 year Forecast
$216.1M+1,138.76%
Avg 3 year Forecast
$326.8M+1,772.96%
TARS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TARS revenue growth forecast

How is TARS forecast to perform vs Biotechnology companies and vs the US market?
Company
165.79%
Industry
37.04%
Market
9.92%
TARS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TARS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TARS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TARS$32.21$48.00+49.02%Buy
PRTA$20.56$68.14+231.43%Buy
BLTE$38.00$58.67+54.39%Strong Buy
SRRK$13.96$27.00+93.41%Strong Buy
AUTL$4.08$9.50+132.84%Strong Buy
View Top Biotech Stocks

Tarsus Pharmaceuticals Stock Forecast FAQ

Is Tarsus Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: TARS) stock is to Buy TARS stock.

Out of 5 analysts, 2 (40%) are recommending TARS as a Strong Buy, 2 (40%) are recommending TARS as a Buy, 1 (20%) are recommending TARS as a Hold, 0 (0%) are recommending TARS as a Sell, and 0 (0%) are recommending TARS as a Strong Sell.

If you're new to stock investing, here's how to buy Tarsus Pharmaceuticals stock.

What is TARS's revenue growth forecast for 2024-2026?

(NASDAQ: TARS) Tarsus Pharmaceuticals's forecast annual revenue growth rate of 165.79% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Tarsus Pharmaceuticals's revenue in 2024 is $17,447,000.On average, 4 Wall Street analysts forecast TARS's revenue for 2024 to be $3,491,250,282, with the lowest TARS revenue forecast at $3,254,558,247, and the highest TARS revenue forecast at $3,808,904,201. On average, 3 Wall Street analysts forecast TARS's revenue for 2025 to be $7,395,590,956, with the lowest TARS revenue forecast at $6,227,837,252, and the highest TARS revenue forecast at $8,208,084,185.

In 2026, TARS is forecast to generate $11,181,876,473 in revenue, with the lowest revenue forecast at $9,375,974,764 and the highest revenue forecast at $12,987,778,181.

What is TARS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: TARS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is TARS's Price Target?

According to 5 Wall Street analysts that have issued a 1 year TARS price target, the average TARS price target is $48.00, with the highest TARS stock price forecast at $59.00 and the lowest TARS stock price forecast at $30.00.

On average, Wall Street analysts predict that Tarsus Pharmaceuticals's share price could reach $48.00 by Mar 6, 2025. The average Tarsus Pharmaceuticals stock price prediction forecasts a potential upside of 49.02% from the current TARS share price of $32.21.

What is TARS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: TARS) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.